Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 4/2005

01-11-2005 | Short communication

Lack of Germ-line Mutations at the Specific BRCA1-IRIS Coding Sequence in 114 Spanish High-risk Breast/ovarian Families

Authors: Miguel de la Hoya, Juan Manuel Fernández, Ana Sánchez de Abajo, Alicia Tosar, Eduardo Díaz-Rubio, Trinidad Caldés

Published in: Familial Cancer | Issue 4/2005

Login to get access
Metadata
Title
Lack of Germ-line Mutations at the Specific BRCA1-IRIS Coding Sequence in 114 Spanish High-risk Breast/ovarian Families
Authors
Miguel de la Hoya
Juan Manuel Fernández
Ana Sánchez de Abajo
Alicia Tosar
Eduardo Díaz-Rubio
Trinidad Caldés
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 4/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-005-1236-x

Other articles of this Issue 4/2005

Familial Cancer 4/2005 Go to the issue

OriginalPaper

Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures

Review

Syndrome of Early Onset Colon Cancers, Hematologic Malignancies & Features of Neurofibromatosis in HNPCC Families with Homozygous Mismatch Repair Gene Mutations

OriginalPaper

Behavioral and Economic Impact of a Familial History of Cancers

Case report

Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation

OriginalPaper

Key word Index Volume 4

OriginalPaper

Survival of Patients with Ovarian Cancer due to a Mismatch Repair Defect
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits